DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)

Stopped The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA

Conditions

• Anemia
• Kidney Diseases
• Renal Failure, Chronic
• Kidney Failure, Chronic

Interventions

• DRUG: DYNEPO (epoetin delta)

Sponsor

Shire